ENvue Medical 

$2.38
0
-$0.08-3.25% Tuesday 20:00

Statistics

Day High
2.54
Day Low
2.35
52W High
162.5
52W Low
0.99
Volume
69,372
Avg. Volume
12,900,805
Mkt Cap
1.9M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

25FebExpected
Q4 0
Q3 2020
Q4 2025
-220
-219.67
-219.33
-219
Expected EPS
N/A
Actual EPS
N/A

Financials

-144.84%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
5.12MRevenue
-7.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FEED. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation competes with NanoVibronix in the medical devices sector, focusing on products for various conditions that can overlap with NanoVibronix's pain management and wound healing solutions.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers a wide range of medical devices that compete directly with NanoVibronix's offerings, especially in the areas of pain management and therapeutic ultrasound technologies.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices segment, competes in the same space as NanoVibronix, offering products that can be used in wound care, surgery, and pain management.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a competitor due to its development and marketing of medical devices, including surgical equipment and orthopaedic devices that can be used in applications similar to NanoVibronix's.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes with NanoVibronix in the orthopaedic market, particularly in products related to bone healing, which may overlap with NanoVibronix's therapeutic ultrasound technology.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers medical devices across various segments, including cardiovascular and neuromodulation, competing with NanoVibronix's pain management solutions.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. competes by offering robotic-assisted surgical systems, which can be used in minimally invasive surgeries, a field where NanoVibronix's pain management and healing solutions could be applied.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation is a competitor in the field of patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring, areas where NanoVibronix's technologies could be beneficial.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. competes with NanoVibronix in the women's health market, offering diagnostic products, medical imaging systems, and surgical products that could be used alongside or in competition with NanoVibronix's solutions.

About

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.
Show more...
CEO
Mr. Stephen R. Brown CPA
Employees
31
Country
US
ISIN
US63008J8844

Listings

0 Comments

Share your thoughts

FAQ

What is ENvue Medical stock price today?
The current price of FEED is $2.38 USD — it has decreased by -3.25% in the past 24 hours. Watch ENvue Medical stock price performance more closely on the chart.
What is ENvue Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ENvue Medical stocks are traded under the ticker FEED.
What is ENvue Medical market cap?
Today ENvue Medical has the market capitalization of 1.9M
What is ENvue Medical revenue for the last year?
ENvue Medical revenue for the last year amounts to 5.12M USD.
What is ENvue Medical net income for the last year?
FEED net income for the last year is -7.41M USD.
How many employees does ENvue Medical have?
As of April 01, 2026, the company has 31 employees.
When did ENvue Medical complete a stock split?
The last stock split for ENvue Medical was on August 12, 2025 with a ratio of 1:10.
Where is ENvue Medical headquartered?
ENvue Medical is headquartered in Arlington Heights, US.